Hospira Yanks Cancer Drugs After Finding Flawed Vials

Law360, New York (July 17, 2012, 5:15 PM EDT) -- Hospira Inc. is recalling shipments of four injectable cancer drugs after finding that a flaw in the glass vials in which the drugs come packaged could result in serious injury, the U.S. Food and Drug Administration announced Friday.

The drugmaker issued the recall after discovering that a total of 19 lots of carboplatin, cytarabine, paclitaxel and methotrexate distributed in the U.S. contained visible particles imbedded in the glass at the neck of the vials that could become dislodged into the solution and subsequently injected into a...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.